Stifel Nicolaus Trims DocGo (NASDAQ:DCGO) Target Price to $6.50

DocGo (NASDAQ:DCGOFree Report) had its target price decreased by Stifel Nicolaus from $8.00 to $6.50 in a research note issued to investors on Tuesday morning, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock.

A number of other analysts also recently weighed in on the stock. Cantor Fitzgerald reduced their target price on shares of DocGo from $13.00 to $11.00 and set an overweight rating on the stock in a research report on Thursday, February 29th. Canaccord Genuity Group lowered their target price on shares of DocGo from $10.00 to $9.00 and set a buy rating for the company in a report on Thursday, April 11th. Needham & Company LLC cut their price target on DocGo from $14.00 to $10.00 and set a buy rating on the stock in a research note on Thursday, February 29th. Finally, BTIG Research lowered their price objective on DocGo from $13.00 to $11.00 and set a buy rating for the company in a research note on Wednesday, April 10th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has a consensus rating of Buy and an average target price of $10.58.

Check Out Our Latest Stock Analysis on DocGo

DocGo Price Performance

DCGO stock opened at $3.61 on Tuesday. DocGo has a 1 year low of $2.78 and a 1 year high of $10.82. The firm has a 50-day moving average of $3.71 and a 200 day moving average of $4.48. The company has a market cap of $376.05 million, a P/E ratio of 51.57, a PEG ratio of 0.39 and a beta of 0.96.

DocGo (NASDAQ:DCGOGet Free Report) last announced its earnings results on Wednesday, February 28th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.07). DocGo had a return on equity of 2.01% and a net margin of 1.10%. The firm had revenue of $199.25 million during the quarter, compared to the consensus estimate of $195.48 million. On average, equities research analysts expect that DocGo will post 0.31 earnings per share for the current fiscal year.

Insider Activity at DocGo

In other DocGo news, Director Michael J. Burdiek bought 10,000 shares of DocGo stock in a transaction on Thursday, March 14th. The stock was acquired at an average price of $3.61 per share, with a total value of $36,100.00. Following the acquisition, the director now owns 571,595 shares in the company, valued at $2,063,457.95. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 13.78% of the stock is currently owned by insiders.

Institutional Investors Weigh In On DocGo

Large investors have recently bought and sold shares of the business. Arizona State Retirement System boosted its holdings in shares of DocGo by 8.3% during the 3rd quarter. Arizona State Retirement System now owns 26,516 shares of the company’s stock valued at $141,000 after acquiring an additional 2,042 shares during the last quarter. Worth Venture Partners LLC boosted its holdings in DocGo by 36.3% in the third quarter. Worth Venture Partners LLC now owns 16,028 shares of the company’s stock worth $85,000 after purchasing an additional 4,265 shares during the last quarter. AJOVista LLC purchased a new stake in DocGo during the 4th quarter valued at $25,000. Principal Financial Group Inc. lifted its holdings in shares of DocGo by 25.2% during the 3rd quarter. Principal Financial Group Inc. now owns 25,591 shares of the company’s stock valued at $136,000 after buying an additional 5,154 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of DocGo by 42.5% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,020 shares of the company’s stock worth $128,000 after buying an additional 7,166 shares during the last quarter. 56.44% of the stock is currently owned by institutional investors.

DocGo Company Profile

(Get Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Read More

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.